Robert Redfield - 12 Oct 2025 Form 4 Insider Report for Traws Pharma, Inc. (TRAW)

Role
Chief Medical Officer
Signature
/s/ Robert Redfield
Issuer symbol
TRAW
Transactions as of
12 Oct 2025
Net transactions value
$0
Form type
4
Filing time
15 Oct 2025, 20:09:39 UTC
Previous filing
03 Apr 2024
Next filing
16 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Redfield Robert Chief Medical Officer C/O TRAWS PHARMA, INC., 12 PENNS TRAIL, NEWTON /s/ Robert Redfield 15 Oct 2025 0002018274

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRAW Stock Option (right to purchase) Award $0 +32,406 $0.000000 32,406 12 Oct 2025 Common Stock 32,406 $3.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest 100% on the first anniversary of the grant date.